Evidence map›Paper›PMID 31818922›Full record

ReviewJournal of immunology (Baltimore, Md. : 1950)2019

The Plasticity of Newly Formed B Cells.

Natalia V Giltiay, Daniela Giordano, Edward A Clark

Abstract readReview
In one paragraph

Review in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Importance of B cells (Review).International journal of molecular medicine · 2026
    Review
  3. Article
  4. Review
  5. B cells and atherosclerosis: A HIV perspective.Journal of cellular physiology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Role of B cells as antigen presenting cells.Frontiers in immunology · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Frontiers in cellular and infection microbiology · 2021
    Article
  19. Article
  20. Regulation of Alloantibody Responses.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natalia V GiltiayDivision of Rheumatology, Department of Medicine, University of Washington, Seattle, WA 98109; and giltiayn@uw.edu eaclark@uw.edu.ORCID 0000-0001-7284-514X
Daniela GiordanoDepartment of Immunology, University of Washington, Seattle, WA 98109.ORCID 0000-0001-8362-7017
Edward A ClarkDepartment of Immunology, University of Washington, Seattle, WA 98109 giltiayn@uw.edu eaclark@uw.edu.ORCID 0000-0001-8061-5475

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Programming protective immunity by targeting antigens to the CD180 receptorR01AI052203 · NIAID · UNIVERSITY OF WASHINGTON · PI FULLER, DEBORAH H. · 2003 to 2019
$6.3M
Role of B cell activating factor (BAFF) in B cell responses and autoimmunityR01AI044257 · NIAID · UNIVERSITY OF WASHINGTON · PI GILTIAY, NATALIA V · 1999 to 2020
$3.7M
NCATS NIH HHS UL1 TR002319NIAID NIH HHS R01 AI044257NIAID NIH HHS R01 AI052203
6 · The paper itself

Abstract

Newly formed B cells (NF-B cells) that emerge from the bone marrow to the periphery have often been referred to as immature or transitional B cells. However, NF-B cells have several striking characteristics, including a distinct BCR repertoire, high expression of AID, high sensitivity to PAMPs, and the ability to produce cytokines. A number of findings do not support their designation as immature because NF-B cells have the potential to become Ab-producing cells and to undergo class-switch recombination. In this review, we provide a fresh perspective on NF-B cell functions and describe some of the signals driving their activation. We summarize growing evidence supporting a role for NF-B cells in protection against infections and as a potential source of autoantibody-producing cells in autoimmune diseases such as systemic lupus erythematosus.

Indexed as

AICDA (Activation-Induced Cytidine Deaminase)AnimalsAutoantibodiesAutoimmunityCell PlasticityCytidine DeaminaseHumansImmunoglobulin Class SwitchingInfectionsLupus Erythematosus, SystemicLymphocyte ActivationMicePrecursor Cells, B-LymphoidAICDA (Activation-Induced Cytidine Deaminase)AutoantibodiesCytidine Deaminase

Identifiers

PMID31818922
PMCPMC6961804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.